Overview

Study of CMP-CPS-001 in Healthy Volunteers

Status:
RECRUITING
Trial end date:
2025-08-01
Target enrollment:
Participant gender:
Summary
The objective of this clinical study is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple ascending doses of CMP-CPS-001 administered as a subcutaneous injection in adult healthy volunteers.
Phase:
PHASE1
Details
Lead Sponsor:
CAMP4 Therapeutics Corporation